migalastat
ItalyDrugs containing this active substance
-
It is used for the long-term treatment of Fabry disease in adults and adolescents (from 12 years of age and older) who have certain genetic mutations. It works by stabilizing the enzyme naturally produced by the body to reduce the accumulation of a fatty substance (GL-3) in the organs.
Form: capsules, hard gelatin
Active substance Dosage migalastat - ATC: A16AX14
Manufacturer: AMICUS THERAPEUTICS EUROPE LIMITED